Triple dose of Novo Nordisk drug delivers 19% weight loss in trials

All NewsSeptember 15, 2025

Danish pharma group seeks to broaden options and stay competitive with Eli Lilly

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent